April 18, 2019

The Canadian federal government is going where the U.S. (for now) is not: namely allowing provinces to channel federal agricultural funds into commercial cannabis production on the provincial level. The program is called the Canadian Agricultural Partnership (or CAP), which is a $2.2 billion annual initiative designed to support agricultural businesses across the country. So […]

by

Although Canopy Growth Corp (TSE:WEED) (NYSE:CGC) (FRA:11L1) delivered an unexpected surprise to the market yesterday, Canadian weedstocks have reacted with a collective yawn. This may be somewhat surprising to investors—many of whom were expecting this cross border MA to send shock waves throughout the market. We explore further. To recap, Canopy Growth administered an official […]

by

As cannabidiol (CBD) becomes more mainstream, the ingredient has become ubiquitous, popping up in everything from cosmetics to beverages to pet products.  CBD is a non-psychoactive natural compound found in the marijuana plant, which does not cause the mood-altering effects associated with tetrahydrocannabinol (THC). This year alone, brand names and retail stores have embraced the ingredient […]

by

Gov. Brian Kemp has signed into law District 67 State Rep. Micah Gravley’s bill to allow the cultivation, manufacturing and dispensing of low THC oil in Georgia. Kemp signed House Bill 324, the Georgia’s Hope Act, on Wednesday, April 17, at the State Capitol in Atlanta. Gravley, R-Douglasville, whose district includes parts of Paulding and […]

by

CannPal Animal Therapeutics Ltd (ASX:CP1) is being recognised for its robust and leading research into medicinal cannabis treatments for animals through participation in Australia’s largest veterinary conference and publication of its first research abstract. This will provide the company the opportunity to directly present to 1,400 veterinarians at the Australian Veterinary Association (AVA) Innovation, Research […]

by

NEW YORK, April 17, 2019 /PRNewswire/ — Researchers and scientists are constantly developing new, innovative medicines to effectively treat patients. However, the cost to conduct clinical trials and then receive approval to commercialize a drug is absurdly expensive. The Tufts Center for the Study of Drug Development estimated that in 2017, it cost pharmaceutical companies […]

by

Given how often California’s regulatory state ensnares mundane things like plastic straws and apartment buildings, it should come as no surprise that the state’s now-legal recreational cannabis industry is having a hell of a time navigating a new world of red tape and restrictions. Causing particular grief is one of the Golden State’s more infamous laws: […]

by

Although it may not be obvious during these Trump-rattled times, we’re in the midst of a psychedelic revival. There is more interest than ever before in experimenting with LSD, magic mushrooms, ayahuasca, ketamine, and other psychedelic drugs. This renaissance is happening without all the fanfare of the day-glo Sixties, when lysergic acid diethylamide (LSD) escaped from […]

by

A Texas House committee unanimously approved a bill on Wednesday to expand the state’s medical marijuana program by adding over a dozen health conditions that would qualify patients for participation. And additional cannabis-related legislation is on the horizon, too, with lawmakers in position to potentially vote on marijuana decriminalization and hemp legalization in short order. […]

by

WASHINGTON, April 18, 2019 (GLOBE NEWSWIRE) — New Frontier Data, the authority in data analytics and business intelligence on the global cannabis industry, releases Global Cannabis Report: 2019 Industry Outlook , estimating the global total addressable cannabis market (regulated and illicit) at $344 billion USD and identifying the top five regional markets to be Asia […]

by